Stratifin (SFN) (N-Term) Peptide
SFN
Reactivité: Humain
Hôte: Synthetic
BP, WB
-
- Antigène Tous les produits 14-3-3 sigma/SFN (SFN)
- 14-3-3 sigma/SFN (SFN) (Stratifin (SFN))
- Protein Region
- N-Term
- Origine
- Humain
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Séquence
- IEQKSNEEGS EEKGPEVREY REKVETELQG VCDTVLGLLD SHLIKEAGDA
- Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-SFN Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Stock
- -20 °C
- Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Antigène
- 14-3-3 sigma/SFN (SFN) (Stratifin (SFN))
- Synonymes
- YWHAS Peptide, Er Peptide, Mme1 Peptide, Ywhas Peptide, stratifin Peptide, SFN Peptide, Sfn Peptide
- Sujet
-
SFN is a p53-regulated inhibitor of G2/M progression. It is an adapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathways. It binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif. Binding generally results in the modulation of the activity of the binding partner. When bound to KRT17, regulates protein synthesis and epithelial cell growth by stimulating Akt/mTOR pathway. It may also regulate MDM2 autoubiquitination and degradation and thereby activate p53/TP53.
Alias Symbols: SFN,HME1,
Protein Size: 248 - ID gène
- 2810
- NCBI Accession
- NP_006133
- UniProt
- P31947
-
Vous êtes ici:
